RAPA-501 Therapy for ALS Expanded Access Protocol

Sponsor:

Rapa Therapeutics LLC

Code:

NCT06169176

Conditions

Amyotrophic Lateral Sclerosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RAPA-501 Autologous T cells

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information